rethinkPeptides Search
Menu
Study breakdown

Single Dose of Neutrophil Peptide 1 During Surgery Speeds Early Nerve Recovery After Crush Injury

AnimalModerate evidence
The takeaway

A single intraoperative dose of neutrophil peptide 1 improved nerve conduction velocity, sciatic functional index, and muscle fiber area at 4 weeks after peripheral nerve crush injury in rats.

Single dose

intraoperative neutrophil peptide 1 improved functional nerve recovery at 4 weeks post-crush

What the researchers found

Single intraoperative administration of neutrophil peptide 1 (10 μg/mL) improved nerve conduction velocity, sciatic functional index, and tibialis anterior muscle fiber cross-sectional area at 4 weeks post-crush injury compared to saline controls.

Why it matters

Peripheral nerve injuries are common and recovery is often slow and incomplete. A single-dose peptide treatment applied during surgery is far more practical than repeated injections, making clinical translation more feasible.

The numbers in context

Single intraoperative dose; improved nerve conduction and functional recovery in early weeks post-injury.

How the study worked

Rat sciatic nerve crush injury model. Single intraoperative dose of 10 μg/mL neutrophil peptide 1 or saline. Sciatic functional index, nerve electrophysiology, histology (H&E staining), muscle wet weight, and myelinated fiber counts assessed at 4 and 8 weeks.

Who was studied

Rats with sciatic nerve crush injury

What this study cannot tell us

Functional improvements at 4 weeks without corresponding structural changes raise questions about the durability and mechanism of benefit. No differences at 8 weeks for some measures suggest the effect may be acceleration of early recovery rather than enhanced overall regeneration. Small animal model.

How to read the evidence

Preclinical rat study with functional and structural outcome measures. Functional improvements are clear but structural endpoints were non-significant, limiting mechanistic conclusions.

When this study was published

Published in 2020. The non-immune functions of antimicrobial peptides continue to be explored.

The bigger picture

Finding treatments that can be applied during nerve surgery to accelerate recovery would be transformative for trauma patients. This single-dose approach with an innate immune peptide suggests that the body's own defense molecules could be repurposed for nerve repair.

Questions still open

  • Does neutrophil peptide 1 speed recovery or improve final regeneration outcomes?
  • What is the mechanism by which a single dose of an antimicrobial peptide promotes nerve function?
  • Would higher doses or different formulations provide more sustained benefits?

Common questions

What is neutrophil peptide 1?
Neutrophil peptide 1 is a defensin — a natural antimicrobial peptide produced by white blood cells. Beyond fighting infections, it appears to have regenerative properties for nerve tissue.
Why is a single dose important?
Previous studies required repeated injections over weeks, which is impractical clinically. A single dose applied during surgery is far easier to implement in real medical practice.

Read the original research

Intraoperative single administration of neutrophil peptide 1 accelerates the early functional recovery of peripheral nerves after crush injury.

Neural regeneration research, 15(11), 2108-2115

Citation

Yuan, Yu-Song; Niu, Su-Ping; Yu, Fei; Zhang, Ya-Jun; Han, Na; Lu, Hao; Yin, Xiao-Feng; Xu, Hai-Lin; Kou, Yu-Hui. (2020). Intraoperative single administration of neutrophil peptide 1 accelerates the early functional recovery of peripheral nerves after crush injury.. Neural regeneration research, 15(11), 2108-2115. https://doi.org/10.4103/1673-5374.282270